Histopathological (granulomas, perineural inflammation, etc.)and immunological features [e.g. B cells/plasma cells (CD20/CD138) and T cells (CD3,CD4,CD8)] were scored and correlated with durable tumor response [i.e. complete response (CR) persisting beyond 6 months after treatment]. This evidence concerns the gene CD4 and neoplasm.